Caprelsa Interactions
There are 312 drugs known to interact with Caprelsa (vandetanib), along with 10 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 202 are major, 100 are moderate, and 10 are minor.
- View all 312 medications that may interact with Caprelsa
- View Caprelsa alcohol/food interactions (1)
- View Caprelsa disease interactions (10)
Most frequently checked interactions
View interaction reports for Caprelsa (vandetanib) and the medicines listed below.
- Actemra (tocilizumab)
- Adempas (riociguat)
- Afinitor (everolimus)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- Amicar (aminocaproic acid)
- Aptivus (tipranavir)
- Aranesp (darbepoetin alfa)
- Blincyto (blinatumomab)
- Bosulif (bosutinib)
- Cerdelga (eliglustat)
- Creon (pancrelipase)
- Cymbalta (duloxetine)
- Entyvio (vedolizumab)
- Esbriet (pirfenidone)
- Gleevec (imatinib)
- Isentress (raltegravir)
- Kalydeco (ivacaftor)
- Kynamro (mipomersen)
- Nulojix (belatacept)
- Nydrazid (isoniazid)
- Prolia (denosumab)
- Pulmozyme (dornase alfa)
- Rapamune (sirolimus)
- Revlimid (lenalidomide)
- Sabril (vigabatrin)
- Soliris (eculizumab)
- Tecentriq (atezolizumab)
- Trizivir (abacavir / lamivudine / zidovudine)
- Truvada (emtricitabine / tenofovir)
Caprelsa alcohol/food interactions
There is 1 alcohol/food interaction with Caprelsa (vandetanib).
Caprelsa disease interactions
There are 10 disease interactions with Caprelsa (vandetanib) which include:
- QT prolongation
- lung toxicity
- heart failure
- hemorrhage
- hepatic impairment
- hypertension
- hypothyroidism
- ischemic attack
- renal impairment
- RPL syndrome
More about Caprelsa (vandetanib)
- Caprelsa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: EGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.